M&A Deal Summary

Care Access Acquires IBPClin

On June 29, 2022, Care Access acquired life science company IBPClin

Acquisition Highlights
  • This is Care Access’ 1st transaction in the Life Science sector.
  • This is Care Access’ 1st transaction in Brazil.

M&A Deal Summary
Date 2022-06-29
Target IBPClin
Sector Life Science
Buyer(s) Care Access
Deal Type Add-on Acquisition

Target

IBPClin

Rio de Janeiro, Brazil
website
IBPClin is a Clinical Trial Center that has been involved in trials to develop new drugs for different diseases. It specializes in running clinical trials on drugs in phases 2, 3, and 4. IBPClin is based in Rio de Janeiro, Brazil.

Search 192,723 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Care Access

Boston, Massachusetts, United States

website

Category Company
Sector Life Science
DESCRIPTION

Care Access is a decentralized research organization (DRO) that breaks down traditional barriers in clinical research for patients, sponsors, and physicians. Its innovative model brings decentralized trials, Sites On Demand™, Virtual PIs, and Mobile Sites to previously unreachable patient populations to expand the impact of clinical research. Care Access is based in Boston, Massachusetts.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (Brazil) 1 of 1
Year (2022) 1 of 1
Mergr

Product

Company

Legal